Archives

by in
Entry Author Date Location
Texas Cancer Center Seeks to Speed Discovery with Applied Research 12/03/14 Texas
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
MD Anderson Showcases “Moon Shots” Progress in Fight Against Cancer 11/03/14 Texas
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Sanofi Punts Cancer Drug Back to Merrimack 06/19/14 Boston
A Few Raindrops Amid Texas Biotech IPO Drought 05/30/14 Texas
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
Deal Aims to Grow “Humanized” Organs in Pigs for Transplantation 05/06/14 San Diego
Indi Reels In $47M To Push Launch Of Lung Cancer Diagnostic 04/29/14 Seattle
Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO 03/10/14 Boston
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
Houston’s MD Anderson Partners With Pfizer on Cancer Immunotherapies 01/08/14 Texas
Enzymatics Snares Boulder-based ArcherDx For Diagnostics Play 09/06/13 Boston
Clovis Oncology Closes $275M Offering Following Two Pivotal Weeks 06/18/13 Boulder/Denver
Clovis Oncology Boosts Public Offering to $240M After Stock Booms 06/12/13 Boulder/Denver
Clovis Oncology to Raise $170M as Stock Price Booms Following ASCO 06/10/13 Boulder/Denver
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
Ziopharm Goes Lean to Stretch Funds for New Synthetic Biology Focus 04/09/13 New York
Cerulean Pharma Fails to Extend Lives in Lung Cancer Study 03/22/13 Boston
Cerulean Pharma Arrives at Turning Point With Cancer Drug 03/06/13 Boston
Oncothyreon Cancer Drug Fails in Final Trial; Shares Tank 12/19/12 Seattle
Scarcity of Samples Threatens Personalized Medicine 07/23/12 National
Cerulean Pharma Adds $15M to Further Nano-Drug Platform 12/15/11 Boston
Former Genzyme Boss Henri Termeer Gives $10M to MGH for Personalized Medicine 09/13/11 Boston
Allegro Gets Another $5.4M 07/07/11 Boston
Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment 07/05/11 Boston
Genentech Gears Up for ASCO, Pushing Data on Personalized Cancer Medicine 05/18/11 San Francisco
Pfizer Lung Cancer Drug to Get Priority Review 05/17/11 New York
KEW, Led by Millennium Co-Founder, Seeks to Bring Big-Time Cancer Care to Community Clinics 04/27/11 Boston
T2 Biosystems, On-Q-ity, and GnuBIO Report Progress in Hunting for Signs of Disease 04/07/11 Boston
Page 1 of 2 next page »